Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janux Therapeutics
Janux Therapeutics
Why Janux Therapeutics Shares Rose 33.1% This Week
Why Janux Therapeutics Shares Rose 33.1% This Week
Motley Fool
Janux Therapeutics
oncology
JANX007
clinical trials
metastatic castration-resistant prostate cancer
Flag link:
Janux doses first subject in Phase I prostate cancer therapy trial
Janux doses first subject in Phase I prostate cancer therapy trial
Clinical Trials Arena
Janux Therapeutics
JANX007
prostate cancer
clinical trials
Flag link:
Merck-partnered Janux hires CMO as its bispecifics near clinic
Merck-partnered Janux hires CMO as its bispecifics near clinic
Fierce Biotech
Janux Therapeutics
Merck
bispecifics
Flag link:
Stealthy biotech Janux nabs $125M and joins chase to direct T cells to solid tumors
Stealthy biotech Janux nabs $125M and joins chase to direct T cells to solid tumors
MedCity News
Janux Therapeutics
R&D
solid tumors
Flag link:
Janux raises $56M to take safer T-cell engagers into the clinic
Janux raises $56M to take safer T-cell engagers into the clinic
Fierce Biotech
Janux Therapeutics
T-cell engager
Flag link:
Janux pairs up with Merck for $1B-plus T-cell engager deal
Janux pairs up with Merck for $1B-plus T-cell engager deal
Fierce Biotech
Merck
Janux Therapeutics
R&D
T-cell engager
cancer
Flag link:
